Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions and methods for targeting CLEC12A-expressing cancers

Compositions and methods for targeting CLEC12A-expressing cancers

US Patent 11951129 · Granted Apr 9, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CD83-binding chimeric antigen receptors2025
Bispecific antibody for cancer immunotherapy2024
Chimeric antigen receptors with mutated CD28 costimulatory domains2024
CAR T cells that target B-cell antigens2024
Compositions and methods for targeting CD99-expressing cancers2024
Compositions and methods for targeting CD33-expressing cancers2024
CD123-binding chimeric antigen receptors2024
Artificial antigen presenting cells for genetic engineering of immune cells2022
Recombinant CD123-binding antibodies2022
Compositions and methods for targeting CD33-expressing cancers2022
TIM3-binding chimeric antigen receptors2022
Chimeric antigen receptors with enhanced NFκB signaling2022